JP2006505542A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505542A5
JP2006505542A5 JP2004541451A JP2004541451A JP2006505542A5 JP 2006505542 A5 JP2006505542 A5 JP 2006505542A5 JP 2004541451 A JP2004541451 A JP 2004541451A JP 2004541451 A JP2004541451 A JP 2004541451A JP 2006505542 A5 JP2006505542 A5 JP 2006505542A5
Authority
JP
Japan
Prior art keywords
gel material
material composition
film
soluble polymer
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004541451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505542A (ja
JP5248739B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/020579 external-priority patent/WO2004030658A1/en
Publication of JP2006505542A publication Critical patent/JP2006505542A/ja
Publication of JP2006505542A5 publication Critical patent/JP2006505542A5/ja
Application granted granted Critical
Publication of JP5248739B2 publication Critical patent/JP5248739B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004541451A 2002-10-01 2003-06-27 腸溶性調製物 Expired - Lifetime JP5248739B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41518702P 2002-10-01 2002-10-01
US60/415,187 2002-10-01
PCT/US2003/020579 WO2004030658A1 (en) 2002-10-01 2003-06-27 Enteric composition for the manufacture of soft capsule wall

Publications (3)

Publication Number Publication Date
JP2006505542A JP2006505542A (ja) 2006-02-16
JP2006505542A5 true JP2006505542A5 (https=) 2006-08-17
JP5248739B2 JP5248739B2 (ja) 2013-07-31

Family

ID=32069824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004541451A Expired - Lifetime JP5248739B2 (ja) 2002-10-01 2003-06-27 腸溶性調製物

Country Status (14)

Country Link
US (2) US8685445B2 (https=)
EP (2) EP1545475B1 (https=)
JP (1) JP5248739B2 (https=)
CN (1) CN1688294A (https=)
AU (1) AU2003299191A1 (https=)
CA (1) CA2500663C (https=)
CY (1) CY1118258T1 (https=)
DK (2) DK1545475T3 (https=)
ES (2) ES2500316T3 (https=)
HU (1) HUE031650T2 (https=)
MX (1) MXPA05003524A (https=)
PT (2) PT2772250T (https=)
SI (2) SI2772250T1 (https=)
WO (1) WO2004030658A1 (https=)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
CN101351196B (zh) 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
CA2627292C (en) 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
US20070148248A1 (en) * 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
JP5183104B2 (ja) * 2006-06-19 2013-04-17 森下仁丹株式会社 口臭除去用多重ソフトカプセル
GB0706178D0 (en) * 2007-03-29 2007-05-09 Univ Aston Enteric pharmaceutical capsules
WO2009064814A2 (en) 2007-11-12 2009-05-22 Pharmaceutics International, Inc. Tri-molecular complexes and their use in drug delivery systems
WO2009062356A1 (en) * 2007-11-13 2009-05-22 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin enteric hard capsule shell and preparation method thereof
EP2293782B1 (en) 2008-05-06 2015-08-12 Dexcel Pharma Technologies Ltd. Stable benzimidazole formulation
US8309107B2 (en) 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
CN102307576A (zh) 2008-12-15 2012-01-04 班纳制药公司 用于增强水不溶性活性剂的释放和吸收的方法
WO2010117873A2 (en) 2009-04-06 2010-10-14 Banner Pharmacaps, Inc. Progesterone solutions for increased bioavailability
US20130115285A1 (en) * 2010-02-12 2013-05-09 Eric H. Van Ness Enteric coating compositions and methods of making and using the same
EP3354335A1 (en) 2010-10-26 2018-08-01 Capsugel Belgium NV Bulk enteric capsule shells
EP3446713A3 (en) 2012-05-02 2019-05-15 Capsugel Belgium NV Aqueous dispersions of controlled release polymers and shells and capsules thereof
EP2968081A4 (en) 2013-03-15 2016-08-10 Banner Life Sciences Llc MOLLE ENTERIC CAPSULES NOT CONTAINING GELATIN
CA2909591C (en) * 2013-04-23 2017-03-28 Zx Pharma, Llc Enteric coated multiparticulate composition with proteinaceous subcoat
US9504656B2 (en) 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
CA2926335C (en) 2013-10-30 2021-11-23 Banner Life Sciences Llc Enteric soft capsules comprising polyunsaturated fatty acids
US20160256399A1 (en) 2013-11-04 2016-09-08 Capsugel Belgium Nv Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
ES2713157T3 (es) 2014-02-28 2019-05-20 Banner Life Sciences Llc Cápsulas blandas entéricas de liberación controlada de ésteres de fumarato
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10772842B2 (en) 2015-01-09 2020-09-15 Patheon Softgels Inc. Abuse-deterrent opioids
US10182992B2 (en) 2014-04-07 2019-01-22 Patheon Softgels Inc. Abuse-deterrent controlled release formulations
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
WO2015200563A1 (en) * 2014-06-26 2015-12-30 Banner Life Sciences Llc Enhanced bioavailability of polysaturated fatty acids
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
KR101917334B1 (ko) 2014-10-06 2018-11-09 후지 캡슐 가부시키가이샤 장용성 심리스 소프트 캡슐의 제조 방법
CA2960631C (en) 2014-10-06 2018-06-05 Fuji Capsule Co., Ltd. Method of manufacturing enteric soft capsule
AU2015328676B2 (en) * 2014-10-08 2017-07-20 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
US10363254B2 (en) * 2015-03-31 2019-07-30 University Of Vermont And State Agricultural College Methods for treating cryptosporidiosis using triazolopyridazines
US10182993B2 (en) 2015-04-06 2019-01-22 Patheon Softgels Inc. Compositions for colonic delivery of drugs
WO2017136617A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
PL239878B1 (pl) 2016-03-30 2022-01-24 Gdanski Univ Medyczny Wodna kompozycja oraz sposób wytwarzania dojelitowych elastycznych filmów do sporządzania kapsułek z wodnej kompozycji oraz dojelitowy elastyczny film do sporządzania kapsułek miękkich
NL2017219B1 (en) * 2016-07-22 2018-01-30 Rousselot B V Low cross-linking gelatine
EA201992116A1 (ru) 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи Фармацевтические составы флороглюцинола и триметилфлороглюцинола
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
AU2019236217B2 (en) 2018-03-15 2025-02-20 R.P. Scherer Technologies, Llc Enteric softgel capsules
CN108619523B (zh) * 2018-03-23 2020-06-30 浙江工业大学 一种可用于快速热塑包衣制剂的包衣膜片及其制备方法
WO2020144591A2 (en) * 2019-01-09 2020-07-16 Antony Benny Preparation of purified withanoside x from withania somnifera plant materials and its medicinal use for the treatment of health disorders
CN109566829A (zh) * 2019-02-11 2019-04-05 广东国方医药科技有限公司 牡丹籽油肠溶凝胶糖果及其制备方法
US11439653B1 (en) 2021-03-30 2022-09-13 Epalex Corporation Fospropofol formulations
US11478490B1 (en) 2021-03-30 2022-10-25 Epalex Corporation Fospropofol formulations
US11628178B2 (en) 2019-03-26 2023-04-18 Epalex Corporation Fospropofol methods and compositions
US11547714B2 (en) 2020-02-05 2023-01-10 Epalex Corporation Fospropofol salts, methods and compositions
MX2021013488A (es) 2019-05-07 2021-12-10 Bausch Health Ireland Ltd Formulaciones liquidas de dosis oral de metilnaltrexona.
US20220249455A1 (en) * 2019-07-15 2022-08-11 R.P. Scherer Technologies, Llc Enteric proton pump inhibitor softgel capsule
US11903918B2 (en) 2020-01-10 2024-02-20 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
WO2021224138A1 (en) 2020-05-02 2021-11-11 Bausch Health Ireland Limited Methods of reducing mortality risk in subjects suffering from an underlying disease or condition by administration of methylnaltrexone
CA3119012C (en) * 2021-05-18 2023-10-17 Gelentroceutics Inc. Formulation of intrinsically acid-resistant vegetarian-based and gelatin-based soft gel capsules for pharmaceutical/nutraceutical products
US20250387338A1 (en) 2022-06-21 2025-12-25 Nutrition & Biosciences Usa 1, Llc Film forming delayed/enteric formulations for hard shell capsules, films and coatings
CN121263207A (zh) * 2023-06-06 2026-01-02 R·P·谢勒技术有限公司 氨溴索液体调配物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826666A (en) * 1972-07-20 1974-07-30 Parke Davis & Co Enteric capsules
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
GR78492B (https=) 1982-03-26 1984-09-27 Warner Lambert Co
US4790881A (en) * 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
DE3222476A1 (de) 1982-06-15 1983-12-15 Warner-Lambert Co., 07950 Morris Plains, N.J. Magensaftresistente weichgelatinekapseln und verfahren zu ihrer herstellung
US4518433A (en) 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
US4500453A (en) * 1984-06-29 1985-02-19 Dynagel Incorporated Cross-linked protein composition using aluminum salts of acetic acid
US4816259A (en) 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US5194464A (en) * 1988-09-27 1993-03-16 Takeda Chemical Industries, Ltd. Enteric film and preparatoin thereof
US6482516B1 (en) 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US5330759A (en) 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
KR20010012402A (ko) * 1997-05-09 2001-02-15 세이지 파마슈티칼스, 인크. 안정한 약제학적 경구 투여형
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6193999B1 (en) * 1999-03-01 2001-02-27 Banner Pharmacaps, Inc. Gum acacia substituted soft gelatin capsules
DE19922537A1 (de) 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
ATE284205T1 (de) * 1999-10-01 2004-12-15 Natco Pharma Ltd Magensaftresistente gelartige weichkapsel
EP1184033A1 (en) 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
AU2003274683A1 (en) * 2002-08-02 2004-02-23 Scitech Centre NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.

Similar Documents

Publication Publication Date Title
JP2006505542A5 (https=)
ES2500316T3 (es) Composición entérica para la fabricación de una cubierta de cápsula blanda
TWI257871B (en) Pharmaceutical formulation
JPS56127322A (en) Enteric coating material composition for solid drug
RU2000131592A (ru) Фармацевтическая композиция, покрытая энтеросолюбильной оболочкой, и способ ее получения
KR20120079836A (ko) 내산성 캡슐
EP3524271A1 (en) Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
CA2341024A1 (en) Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
JP2005526819A (ja) ポリサッカライドカプセル及びその製造方法
JP5627854B2 (ja) 胃の逆流抵抗性投薬形態
RU2000104866A (ru) Пероральный фармацевтический препарат, содержащий соединение, обладающее противоязвенным действием, и способ получения указанного препарата
US20090010975A1 (en) Non-transparent composition for film
JPH0441422A (ja) 大腸崩壊性硬質カプセル
JP5489471B2 (ja) Peg充填硬質カプセル剤のバンドシール
JP2013525394A (ja) 経口投与剤形
KR20100095581A (ko) 다-영역 필름
JP2004531399A5 (https=)
JP2005537233A5 (https=)
JP2007524646A (ja) 膨潤可能なコーティングを有する薬学的組成物
IL276943B1 (en) Enteric softgel capsules
CN102369022A (zh) 硬胶囊
CN101708171B (zh) 一种肠溶植物空心胶囊
MX2012009595A (es) Composicion de encapsulacion de rapida liberacion.
CN110191723B (zh) 表现出改善的凝胶助剂的沉积的硬胶囊及其制备方法
JP2013253039A (ja) 口腔内溶解型フィルム製剤